Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CEREBRAINT.NS Stock Summary
Top 10 Correlated ETFs
CEREBRAINT.NS
In the News
CEREBRAINT.NS Financial details
Company Rating
Sell
Market Cap
830.12M
Income
-555.06M
Revenue
500.71M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
178
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-3.21
Forward P/E
-
PEG
0.11
P/S
1.72
P/B
0.34
P/C
-
P/FCF
-
Quick Ratio
0.9
Current Ratio
1.47
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-4.98
EPS next Y
-
EPS next Q
-
EPS this Y
-90.61%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.57%
Revenue last 5Y
-25.88%
Revenue Q/Q
-33.2%
EPS Q/Q
84.72%
-
-
-
-
SMA20
-22.22%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-20%
ROC
-0.08%
Gross Margin
4%
Oper. Margin
-37%
Profit Margin
-50%
Payout
-
Shs Outstand
126.22M
Shs Float
94.07M
-
-
-
-
Target Price
-
52W Range
4.6-12.35
52W High
-47.5%
52W Low
+57.5%
RSI
31
Rel Volume
1.25
Avg Volume
333.68K
Volume
417.75K
Perf Week
-5.97%
Perf Month
-31.89%
Perf Quarter
10.53%
Perf Half Y
6.78%
-
-
-
-
Beta
0.572
-
-
Volatility
0.31%, 0.91%
Prev Close
-3.08%
Price
6.3
Change
-5.97%
CEREBRAINT.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 31.94 | 15.02 | 5.77 | 19.49 | 7.88 | |
Net income per share | 0.36 | 0.94 | 0.1 | 2.31 | 0.23 | |
Operating cash flow per share | -1.62 | -0.83 | -0.45 | -1.46 | -0.18 | |
Free cash flow per share | -1.66 | -6.49 | -0.94 | -1.49 | -0.22 | |
Cash per share | 6.35 | 1.51 | 0.52 | 0.19 | 0.21 | |
Book value per share | 22.28 | 24.29 | 24.13 | 21.75 | 23.79 | |
Tangible book value per share | 22.74 | 24.81 | 24.6 | 21.55 | 23.58 | |
Share holders equity per share | 22.28 | 24.29 | 24.13 | 21.75 | 23.79 | |
Interest debt per share | 0.58 | 1.28 | 1.83 | 3.26 | 4.62 | |
Market cap | 3.13B | 2.13B | 6.28B | 9.33B | 793.53M | |
Enterprise value | 2.46B | 2.13B | 6.45B | 9.65B | 1.2B | |
P/E ratio | 71.12 | 18.59 | 509.08 | 34.04 | 31.56 | |
Price to sales ratio | 0.81 | 1.17 | 8.98 | 4.04 | 0.92 | |
POCF ratio | -16.01 | -21.27 | -115.48 | -53.77 | -39.78 | |
PFCF ratio | -15.68 | -2.7 | -55.3 | -52.92 | -33.42 | |
P/B Ratio | 1.16 | 0.72 | 2.15 | 3.62 | 0.3 | |
PTB ratio | 1.16 | 0.72 | 2.15 | 3.62 | 0.3 | |
EV to sales | 0.64 | 1.17 | 9.23 | 4.18 | 1.4 | |
Enterprise value over EBITDA | 4.22 | 6.01 | 77.5 | 20.51 | 11.68 | |
EV to operating cash flow | -12.6 | -21.25 | -118.63 | -55.62 | -60.29 | |
EV to free cash flow | -12.34 | -2.7 | -56.8 | -54.74 | -50.64 | |
Earnings yield | 0.01 | 0.05 | 0 | 0.03 | 0.03 | |
Free cash flow yield | -0.06 | -0.37 | -0.02 | -0.02 | -0.03 | |
Debt to equity | 0.01 | 0.04 | 0.06 | 0.13 | 0.16 | |
Debt to assets | 0.01 | 0.03 | 0.05 | 0.08 | 0.1 | |
Net debt to EBITDA | -1.14 | -0.01 | 2.06 | 0.68 | 3.97 | |
Current ratio | 2.25 | 2.03 | 3.18 | 1.52 | 1.64 | |
Interest coverage | 15.8 | 12.58 | 1.98 | 7.58 | 1.04 | |
Income quality | -0.99 | -0.7 | -1.39 | -0.43 | -12.92 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.04 | 0.01 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 6.87 | 1.09 | 0.02 | 0.19 | |
Capex to revenue | 0 | -0.38 | -0.08 | 0 | 0 | |
Capex to depreciation | -1.09 | -202.25 | -13.76 | -0.65 | -0.9 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.52 | 22.71 | 7.44 | 33.63 | 11.09 | |
ROIC | 0.06 | 0.1 | 0.01 | 0.11 | 0.53 | |
Return on tangible assets | 0.01 | 0.03 | 0 | 0.06 | 0.01 | |
Graham Net | 12.58 | 5.6 | 9.13 | 1.66 | -0.98 | |
Working capital | 2.38B | 1.51B | 1.85B | 882.06M | 891.65M | |
Tangible asset value | 2.74B | 3.01B | 2.98B | 2.55B | 2.58B | |
Net current asset value | 2.37B | 1.5B | 1.84B | 876.12M | 886.62M | |
Invested capital | 0.01 | 0.04 | 0.06 | 0.13 | 0.16 | |
Average receivables | 2.82B | 3.04B | 2.45B | 2.35B | 1.87B | |
Average payables | 1.27B | 1.35B | 711.36M | 616.65M | 701.07M | |
Average inventory | 93.79M | 79.87M | 190.16M | 243.92M | 341.93M | |
Days sales outstanding | 334.09 | 510.53 | 1.23K | 368.97 | 593.15 | |
Days payables outstanding | 192.78 | 301.6 | 290.52 | 186.53 | 310.02 | |
Days of inventory on hand | 4.53 | 34.24 | 212.13 | 48.58 | 269.44 | |
Receivables turnover | 1.09 | 0.71 | 0.3 | 0.99 | 0.62 | |
Payables turnover | 1.89 | 1.21 | 1.26 | 1.96 | 1.18 | |
Inventory turnover | 80.6 | 10.66 | 1.72 | 7.51 | 1.35 | |
ROE | 0.02 | 0.04 | 0 | 0.11 | 0.01 | |
Capex per share | -0.03 | -5.67 | -0.49 | -0.02 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.08 | 1.37 | 0.62 | 1.6 | 1.07 | |
Net income per share | 0.03 | -0.13 | -0.75 | -1.44 | -2.66 | |
Operating cash flow per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Cash per share | 0.19 | 0.24 | 0.21 | 0.09 | 0 | |
Book value per share | 21.38 | 26.79 | 23.23 | 21.03 | 0 | |
Tangible book value per share | 0 | 26.56 | 0 | 20.82 | 0 | |
Share holders equity per share | 21.38 | 26.79 | 23.23 | 21.03 | 0 | |
Interest debt per share | 0.13 | 4.58 | 0.15 | 3.8 | 0.15 | |
Market cap | 1.68B | 704.63M | 661.48M | 628.34M | 822.88M | |
Enterprise value | 1.71B | 1.11B | 684.51M | 1.04B | 822.88M | |
P/E ratio | 111.44 | -14.32 | -1.98 | -0.97 | -0.69 | |
Price to sales ratio | 12.91 | 5.3 | 9.66 | 3.5 | 6.87 | |
POCF ratio | 829.8 | 301.38 | 314.39 | 296.95 | 388.52 | |
PFCF ratio | 829.8 | 301.38 | 314.39 | 296.95 | 388.52 | |
P/B Ratio | 0.65 | 0.27 | 0.26 | 0.27 | 0 | |
PTB ratio | 0.65 | 0.27 | 0.26 | 0.27 | 0 | |
EV to sales | 13.09 | 8.37 | 9.99 | 5.78 | 6.87 | |
Enterprise value over EBITDA | 80.85 | -102.93 | -10.34 | -8.07 | -4.12 | |
EV to operating cash flow | 841.07 | 476.35 | 325.34 | 489.71 | 388.52 | |
EV to free cash flow | 841.07 | 476.35 | 325.34 | 489.71 | 388.52 | |
Earnings yield | 0 | -0.02 | -0.13 | -0.26 | -0.36 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.16 | 0 | 0.17 | 0 | |
Debt to assets | 0 | 0.1 | 0 | 0.11 | 0 | |
Net debt to EBITDA | 1.08 | -37.81 | -0.35 | -3.18 | 0 | |
Current ratio | 0 | 1.64 | 0 | 1.47 | 0 | |
Interest coverage | 1.32 | -0.35 | -4.16 | -7.71 | -11.73 | |
Income quality | 0.54 | -0.19 | -0.03 | -0.01 | -0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.04 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.87 | 8.73 | 19.8 | 26.1 | 0 | |
ROIC | 0.01 | 0 | -0.03 | -0.05 | 0 | |
Return on tangible assets | 0 | 0 | 0 | -0.04 | 0 | |
Graham Net | 0.19 | -1.11 | 0.21 | -2.4 | 0 | |
Working capital | 22.89M | 891.65M | 23.03M | 652.14M | 0 | |
Tangible asset value | 0 | 2.58B | 0 | 2.34B | 0 | |
Net current asset value | 22.89M | 886.62M | 23.03M | 644.15M | 0 | |
Invested capital | 0 | 0.16 | 0 | 0.17 | 0 | |
Average receivables | 883.75M | 700.43M | 700.43M | 616.52M | 616.52M | |
Average payables | 371.29M | 261.82M | 261.82M | 258.82M | 258.82M | |
Average inventory | 119.27M | 227.54M | 227.54M | 186.29M | 186.29M | |
Days sales outstanding | 0 | 947.88 | 0 | 618.65 | 0 | |
Days payables outstanding | 0 | 375.65 | 0 | 200.86 | 0 | |
Days of inventory on hand | 0 | 326.47 | 0 | 144.57 | 0 | |
Receivables turnover | 0 | 0.09 | 0 | 0.15 | 0 | |
Payables turnover | 0 | 0.24 | 0 | 0.45 | 0 | |
Inventory turnover | 0 | 0.28 | 0 | 0.62 | 0 | |
ROE | 0 | 0 | -0.03 | -0.07 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CEREBRAINT.NS Frequently Asked Questions
What is Cerebra Integrated Technologies Limited stock symbol ?
Cerebra Integrated Technologies Limited is a IN stock and trading under the symbol CEREBRAINT.NS
What is Cerebra Integrated Technologies Limited stock quote today ?
Cerebra Integrated Technologies Limited stock price is $6.3 today.
Is Cerebra Integrated Technologies Limited stock public?
Yes, Cerebra Integrated Technologies Limited is a publicly traded company.